11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
- Contribution to journal › Article
- 2018
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
- Contribution to journal › Article
- 2017
-
Mark
Dietary rose hip exerts antiatherosclerotic effects and increases nitric oxide-mediated dilation in ApoE-null mice
- Contribution to journal › Article
-
Mark
The course and end-points of Alzheimer’s disease according to sociodemographics, apolipoprotein E genotype and cognitive ability.
(2017) Alzheimer's Association International Conference (AAIC), 2017
- Contribution to conference › Poster
- 2014
-
Mark
Assessment of Peptide Chemical Modifications on the Development of an Accurate and Precise Multiplex Selected Reaction Monitoring Assay for Apolipoprotein E Isoforms
- Contribution to journal › Article
-
Mark
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
- Contribution to journal › Article
- 2009
-
Mark
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
- Contribution to journal › Article
- 2007
-
Mark
OxLDL-induced gene expression patterns in CASMC are mimicked in apoE(-/-) mice aortas
- Contribution to journal › Article
- 2003
-
Mark
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
- Contribution to journal › Article
-
Mark
Increased frequency of a new polymorphism in the cycle 2 (cdc2) gene in patients with Alzheimer's disease frontotemporal dementia
- Contribution to journal › Article
